Outlook
The Company’s most recent guidance was given in February 2010. The Company estimates full-year 2010 Group revenues between € 89 million and € 93 million, and an operating profit of € 5 million to € 9 million, including investments in technology and product development in the amount of € 26 million to € 29 million (2009: € 19.3 million). At the occasion of the reporting of the financial results of the second quarter of 2010, MorphoSys reconfirmed full-year guidance.